NFKB1 and neoplasm: That being said, the decreased NF-kB levels in this study might be explained by the fact that cisplatin causes NF-kB inhibition by binding the “kB” regions, which are the NF-kB DNA binding regions, and, as a result, leads to an increase in the apoptosis and necrosis sensitivity of the tumor cells [40].